National Health Investors, Inc. (NYSE:NHI) Declares Quarterly Dividend of $0.92

National Health Investors, Inc. (NYSE:NHI) declared a quarterly dividend on Monday, November 9th. Investors of record on Thursday, December 31st will be given a dividend of $0.92 per share by the real estate investment trust on Friday, January 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.1%. The ex-dividend date is Thursday, December 31st.

National Health Investors has a dividend payout ratio of 115.0% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Analysts expect National Health Investors to earn $4.98 per share next year, which means the company should continue to be able to cover its $3.76 annual dividend with an expected future payout ratio of 75.5%.

National Health Investors Stock Performance

Shares of NHI stock opened at $71.49 on Tuesday. The stock has a market capitalization of $3.51 billion, a PE ratio of 20.66, a price-to-earnings-growth ratio of 4.54 and a beta of 0.51. National Health Investors has a 52-week low of $63.51 and a 52-week high of $91.38. The stock’s 50-day moving average price is $67.80 and its 200 day moving average price is $76.13. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $10.29. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%. The company had revenue of $113.48 million during the quarter, compared to analysts’ expectations of $68.53 million. As a group, equities research analysts forecast that National Health Investors will post 4.76 EPS for the current year.

Analysts Set New Price Targets

Several research firms have issued reports on NHI. Truist Financial cut their target price on National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, September 2nd. National Bank Financial set a $79.00 price target on National Health Investors in a research note on Wednesday, September 9th. Wells Fargo & Company dropped their price objective on National Health Investors from $78.00 to $68.00 and set an “equal weight” rating on the stock in a report on Monday, October 19th. Weiss Ratings cut National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, September 25th. Finally, Zacks Research raised National Health Investors from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 29th. Five research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $81.00.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee.

NHI’s portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans.

The company serves markets across the United States.